Mostrar el registro sencillo del ítem
dc.contributor.author | Garcia-Barreno, Blanca | |
dc.contributor.author | Delgado-Romero, Teresa | |
dc.contributor.author | Benito, Sonia | |
dc.contributor.author | Casas Flecha, Inmaculada | |
dc.contributor.author | Pozo Sanchez, Francisco | |
dc.contributor.author | Cuevas, Maria Teresa | |
dc.contributor.author | Mas-Lloret, Vicente | |
dc.contributor.author | Trento, Alfonsina | |
dc.contributor.author | Rodriguez-Frandsen, Ariel | |
dc.contributor.author | Falcón, Ana | |
dc.contributor.author | Ortín, Juan | |
dc.contributor.author | Nieto, Amelia | |
dc.contributor.author | Melero, Jose Antonio | |
dc.date.accessioned | 2023-02-09T18:18:37Z | |
dc.date.available | 2023-02-09T18:18:37Z | |
dc.date.issued | 2014-05 | |
dc.identifier.citation | J Gen Virol. 2014 May;95(Pt 5):1033-1042. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/15480 | |
dc.description.abstract | Murine hybridomas producing neutralizing mAbs specific to the pandemic influenza virus A/California/07/2009 haemagglutinin (HA) were isolated. These antibodies recognized at least two different but overlapping new epitopes that were conserved in the HA of most Spanish pandemic isolates. However, one of these isolates (A/Extremadura/RR6530/2010) lacked reactivity with the mAbs and carried two unique mutations in the HA head (S88Y and K136N) that were required simultaneously to eliminate reactivity with the murine antibodies. This unusual requirement directly illustrates the phenomenon of enhanced antigenic change proposed previously for the accumulation of simultaneous amino acid substitutions at antigenic sites of the influenza A virus HA during virus evolution (Shih et al., Proc Natl Acad Sci USA, 104 , 6283-6288, 2007). The changes found in the A/Extremadura/RR6530/2010 HA were not found in escape mutants selected in vitro with one of the mAbs, which contained instead nearby single amino acid changes in the HA head. Thus, either single or double point mutations may similarly alter epitopes of the new antigenic site identified in this work in the 2009 H1N1 pandemic virus HA. Moreover, this site is relevant for the human antibody response, as shown by competition of mAbs and human post-infection sera for virus binding. The results are discussed in the context of the HA antigenic structure and challenges posed for identification of sequence changes with possible antigenic impact during virus surveillance. | es_ES |
dc.description.sponsorship | This work was supported in part by grants GR09/0023 (A. N.), GR09/0039 (J. A. M.) and GR09/0040 (I. C.) from Instituto de Salud Carlos III under a special research programme on pandemic flu. Additionally, the Biología Viral Unit is supported currently by grant SAF2012-31217 from Plan Nacional I+D+i. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Cambridge University Press | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.mesh | Animals | es_ES |
dc.subject.mesh | Antibodies, Monoclonal | es_ES |
dc.subject.mesh | Antibodies, Viral | es_ES |
dc.subject.mesh | Antigens, Viral | es_ES |
dc.subject.mesh | Epitopes | es_ES |
dc.subject.mesh | Hemagglutinin Glycoproteins, Influenza Virus | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Influenza A Virus, H1N1 Subtype | es_ES |
dc.subject.mesh | Influenza, Human | es_ES |
dc.subject.mesh | Mice | es_ES |
dc.subject.mesh | Mice, Inbred BALB C | es_ES |
dc.subject.mesh | Molecular Sequence Data | es_ES |
dc.subject.mesh | Mutant Proteins | es_ES |
dc.subject.mesh | Mutation, Missense | es_ES |
dc.subject.mesh | RNA, Viral | es_ES |
dc.subject.mesh | Sequence Analysis, DNA | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.title | Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.identifier.pubmedID | 24531414 | es_ES |
dc.format.volume | 95 | es_ES |
dc.format.number | Pt5 | es_ES |
dc.format.page | 1033-1042 | es_ES |
dc.identifier.doi | 10.1099/vir.0.061598-0 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Plan Nacional de I+D+i (España) | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1465-2099 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1099/vir.0.061598-0 | es_ES |
dc.identifier.journal | The Journal of general virology | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SAF2012-31217 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/GR09/0023 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/GR09/0039 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/GR09/0040 | es_ES |